Silicon nanopore membrane (SNM) for islet encapsulation and immunoisolation under convective transport

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Song, Shang ^a   Faleo, Gaetano ^b   Yeung, Raymond ^a   Kant, Rishi ^a   Posselt, Andrew M ^b   Desai, Tejal A ^a   Tang, Qizhi ^b   Roy, Shuvo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL MEMBRANE; SILICON;

ARTIFICIAL MEMBRANE; CHEMISTRY; CYTOLOGY; DEVICES; DIABETES MELLITUS, TYPE 1; HUMAN; NANOPORE; NANOTECHNOLOGY; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PARTICLE SIZE;

DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MEMBRANES, ARTIFICIAL; NANOPORES; NANOTECHNOLOGY; PARTICLE SIZE; SILICON;

EID: 84961589953     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23679     Document Type: Article

References (50)

1. Shapiro, A. M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. The New England journal of medicine 343, 230-238, doi: 10.1056/NEJM200007273430401 (2000).
2. Markmann, J. F. et al. Insulin independence following isolated islet transplantation and single islet infusions. Annals of surgery 237, 741-749; discussion 749-750, doi: 10.1097/01.SLA.0000072110.93780.52 (2003).
3. Hirshberg, B. et al. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Diabetes care 26, 3288-3295 (2003).
4. Pileggi, A. et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81, 1318-1324, doi: 10.1097/01.tp.0000203858.41105.88 (2006).
5. Biarnes, M. et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia. Diabetes 51, 66-72 (2002).
6. Shapiro, A. M. et al. International trial of the Edmonton protocol for islet transplantation. The New England journal of medicine 355, 1318-1330, doi: 10.1056/NEJMoa061267 (2006).
7. Ishiyama, K., Rawson, J., Omori, K., Mullen, Y. Liver natural killer cells play a role in the destruction of islets after intraportal transplantation. Transplantation 91, 952-960, doi: 10.1097/TP.0b013e3182139dc1 (2011).
8. Ramirez-Victorino, F., Beilke, J. N., Gill, R. G. Both Innate and Adaptive Major Histocompatibility Complex Class I-Dependent Immunity Impair Long-Term Islet Xenograft Survival (vol 40, pg 557, 2008). Transpl P 42, 999-999, doi: DOI 10.1016/j. transproceed.2010.03.102 (2010).
9. Chang, T. M. Semipermeable Microcapsules. Science 146, 524-525 (1964).
10. Colton, C. K. Implantable biohybrid artificial organs. Cell transplantation 4, 415-436 (1995).
11. Beutler, B. et al. Identity of Tumor Necrosis Factor and the Macrophage-Secreted Factor Cachectin. Nature 316, 552-554, doi: 10.1038/316552a0 (1985).
12. Edward, J. T. Citation-Classic-Molecular Volumes and the Stokes-Einstein Equation. Cc/Eng Tech Appl Sci, 14-14 (1986).
13. Kelker, H. C. et al. Three molecular weight forms of natural human interferon-gamma revealed by immunoprecipitation with monoclonal antibody. J Biol Chem 259, 4301-4304 (1984).
14. Berney, T. et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 71, 125-132, doi: 10.1097/00007890-200101150-00020 (2001).
15. Ehrnfelt, C., Kumagai-Braesch, M., Uzunel, M., Holgersson, J. Adult porcine islets produce MCP-1 and recruit human monocytes in vitro. Xenotransplantation 11, 184-194, doi: 10.1046/j.1399-3089.2003.00104.x (2004).
16. Shamlou, S., Kennedy, J. P., Levy, R. P. Amphiphilic networks. X. Diffusion of glucose and insulin (and nondiffusion of albumin) through amphiphilic membranes. Journal of biomedical materials research 35, 157-163 (1997).
17. Oliva, A., Farina, J., Llabres, M. Development of two high-performance liquid chromatographic methods for the analysis and characterization of insulin and its degradation products in pharmaceutical preparations. Journal of chromatography. B, Biomedical sciences and applications 749, 25-34 (2000).
18. Ammendrup, A. et al. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes 49, 1468-1476, doi: 10.2337/diabetes.49.9.1468 (2000).
19. Cnop, M. et al. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 Suppl 2, S97-107 (2005).
20. Dunleavy, M. Polymeric membranes. A review of applications. Medical device technology 7, 14-16, 18-21 (1996).
21. Chu, W., Huen, T., Tu, J., Ferrari, M. Silicon-micromachined direct-pore filters for ultrafiltration. P Soc Photo-Opt Ins 2978, 111-122, doi: 10.1117/12.269961 (1997).
22. Desai, T. A. et al. Microfabricated immunoisolating biocapsules. Biotechnology and bioengineering 57, 118-120 (1998).
23. Fissell, W. H. et al. High-performance silicon nanopore hemofiltration membranes. J Membrane Sci 326, 58-63, doi: 10.1016/j. memsci.2008.09.039 (2009).
24. Kanani, D. M. et al. Permeability-Selectivity Analysis for Ultrafiltration: Effect of Pore Geometry. J Memb Sci 349, 405, doi: 10.1016/j.memsci.2009.12.003 (2010).
25. Conlisk, A. T., Datta, S., Fissell, W. H., Roy, S. Biomolecular Transport Through Hemofiltration Membranes. Annals of biomedical engineering 37, 722-736, doi: 10.1007/s10439-009-9642-0 (2009).
26. Deen, W. M. Hindered transport of large molecules in liquid-filled pores. Aiche J 33, 1409-1425, doi: 10.1002/aic.690330902 (1987).
27. Desai, T. A., Hansford, D. J., Ferrari, M. Micromachined interfaces: new approaches in cell immunoisolation and biomolecular separation. Biomolecular engineering 17, 23-36 (2000).
28. Desai, T. A. et al. Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts. Biomedical microdevices 1, 131-138, doi: 10.1023/A:1009948524686 (1999).
29. Desai, T. A., Hansford, D., Ferrari, M. Characterization of micromachined silicon membranes for immunoisolation and bioseparation applications. J Membrane Sci 159, 221-231, doi: 10.1016/S0376-7388(99)00062-9 (1999).
30. Leoni, L., Desai, T. A. Nanoporous biocapsules for the encapsulation of insulinoma cells: Biotransport and biocompatibility considerations. Ieee T Bio-Med Eng 48, 1335-1341, doi: 10.1109/10.959329 (2001).
31. Leoni, L., Boiarski, A., Desai, T. A. Characterization of nanoporous membranes for immunoisolation: Diffusion properties and tissue effects. Biomedical microdevices 4, 131-139, doi: 10.1023/A:1014639332543 (2002).
32. Sabek, O. M. et al. Characterization of a nanogland for the autotransplantation of human pancreatic islets. Lab on a chip 13, 3675-3688, doi: 10.1039/c3lc50601k (2013).
33. Maher, J. F. Replacement of Renal Function by Dialysis: A Text Book of Dialysis. 312 (Springer Science & Business Media, 1989).
34. Smith, R. A., Fleischman, A. J., Fissell, W. H., Zorman, C. A., Roy, S. A system to measure minute hydraulic permeability of nanometer scale devices in a non-destructive manner. Meas Sci Technol 22, doi: 10.1088/0957-0233/22/4/045802 (2011).
35. Reach, G., Jaffrin, M. Y., Desjeux, J. F. A U-shaped bioartificial pancreas with rapid glucose-insulin kinetics. In vitro evaluation and kinetic modelling. Diabetes 33, 752-761 (1984).
36. Sircar, S. Principles of Medical Physiology. 236 (Thieme, 2008).
37. Zydney, L. J. Z. A. L. Microfiltration and Ultrafiltration. (Marcel Dekker, 1996).
38. Dechadilok, P., Deen, W. M. Hindrance factors for diffusion and convection in pores. Ind Eng Chem Res 45, 6953-6959, doi: 10.1021/Ie051387n (2006).
39. Eck, M. J., Sprang, S. R. The Structure of Tumor Necrosis Factor-Alpha at 2.6-a Resolution-Implications for Receptor-Binding. J Biol Chem 264, 17595-17605 (1989).
40. Thiel, D. J. et al. Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex. Structure 8, 927-936 (2000).
41. Vanoostrum, J., Priestle, J. P., Grutter, M. G., Schmitz, A. The Structure of Murine Interleukin-1-Beta at 2.8-a Resolution. J Struct Biol 107, 189-195 (1991).
42. Burns, D. B., Zydney, A. L. Contributions to electrostatic interactions on protein transport in membrane systems. Aiche J 47, 1101-1114, doi: 10.1002/aic.690470517 (2001).
43. Pujar, N. S., Zydney, A. L. Electrostatic effects on protein partitioning in size-exclusion chromatography and membrane ultrafiltration. J Chromatogr A 796, 229-238, doi: 10.1016/S0021-9673(97)01003-0 (1998).
44. Muthusubramaniam, L. et al. Hemocompatibility of Silicon-Based Substrates for Biomedical Implant Applications. Ann Biomed Eng 39, 1296-1305, doi: 10.1007/s10439-011-0256-y (2011).
45. Fissell, W. H., Humes, H. D., Fleischman, A. J., Roy, S. Initial characterization of a nanoengineered ultrafiltration membrane. J Am Soc Nephrol 13, 602a-602a (2002).
46. Fissell, W. H. et al. Differentiated growth of human renal tubule cells on thin-film and nanostructured materials. Asaio J 52, 221-227, doi: 10.1097/01.mat.0000205228.30516.9c (2006).
47. Papra, A., Gadegaard, N., Larsen, N. B. Characterization of ultrathin poly(ethylene glycol) monolayers on silicon substrates. Langmuir 17, 1457-1460, doi: 10.1021/La000609d (2001).
48. Pavlovic, D., Chen, M. C., Gysemans, C. A., Mathieu, C., Eizirik, D. L. The role of interferon regulatory factor-1 in cytokineinduced mRNA expression and cell death in murine pancreatic beta-cells. Eur Cytokine Netw 10, 403-411 (1999).
49. Ronco, C., Ghezzi, P. M., Brendolan, A., Crepaldi, C., La Greca, G. The haemodialysis system: basic mechanisms of water and solute transport in extracorporeal renal replacement therapies. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association-European Renal Association 13 Suppl 6, 3-9 (1998).
50. Szot, G. L., Koudria, P., Bluestone, J. A. Murine pancreatic islet isolation. Journal of visualized experiments : JoVE, 255, doi: 10.3791/255 (2007).